Form D · Biotechnology
CapsoVision, Inc
Saratoga, CA · CIK 0001378325
Offering snapshot reported Jul 23, 2024 · SEC filing
- Reported sold
- $64.8M Offering amount: $64.8M
- Investors reported
- 114 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Nov 21, 2019 As reported in this filing
Fundraising history
Reported soldDates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.
What changed?
Latest filing versus its linked predecessor, where available.
- Reported sold$54,828,812 → $64,828,822
- Reported investors105 → 114
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 23, 2024 | Amendment | $64,828,822 | $10,000,010vs Oct 19, 2023 | 114 | SEC filing |
| Oct 19, 2023 | Amendment | $54,828,812 | $20,129,974vs Mar 7, 2023 | 105 | SEC filing |
| Mar 7, 2023 | Amendment | $34,698,838 | $22,702,480vs Mar 11, 2021 | 51 | SEC filing |
| Mar 11, 2021 | Amendment | $11,996,358 | $9,096,354vs Nov 26, 2019 | 24 | SEC filing |
| Jun 17, 2020 | Initial | $980,000 | No comparison | 7 | SEC filing |
| Nov 26, 2019 | Initial | $2,900,004 | No comparison | 5 | SEC filing |
| Oct 31, 2018 | Initial | $6,058,958 | No comparison | 11 | SEC filing |
| Oct 31, 2018 | Initial | $8,000,009 | No comparison | 8 | SEC filing |
| Apr 25, 2016 | Initial | $4,599,999 | No comparison | 9 | SEC filing |
| Feb 21, 2014 | Initial | $15,899,997 | No comparison | 6 | SEC filing |
| Oct 26, 2012 | Initial | $3,707,200 | No comparison | 4 | SEC filing |
| Sep 6, 2012 | Initial | $450,000 | No comparison | 3 | SEC filing |
| Jun 28, 2012 | Initial | $589,993 | No comparison | 5 | SEC filing |
| Dec 23, 2011 | Initial | $1,459,997 | No comparison | 8 | SEC filing |
| Feb 8, 2011 | Initial | $2,514,993 | No comparison | 14 | SEC filing |
| Feb 25, 2010 | Initial | $2,549,989 | No comparison | 7 | SEC filing |
| Aug 5, 2009 | Initial | $1,044,009 | No comparison | 4 | SEC filing |
| Oct 10, 2006 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-354278
Source: Form D, filed Jul 23, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| M.L. Chen | Director |
| M L Chen | Director |
| Peter Chou | Director |
| Heidi Chung | Director |
| Weili Dai | Director |
| Eli Harari | Director |
| H.L. Hsieh | Director |
| Hung Hsieh | Director |
| Hung Liang Hsieh | Director |
| Chung Hsu | Director |
| Patty Kuo | Director |
| Howard Lee | Director |
| Matthew Liu | Director |
| Morris Lu | Director |
| Len Mei | Director |
| Chen Tsai | Director |
| Wen Hung Tsai | Director |
| Pen Jung Tseng | Director |
| Kang Huai Wang | Director, Executive |
| Mintze Wu | Director |
| Stephen S. C. Wu | Director |
| Hsiu Hsien Wu | Director |
| Ying Hui Wu | Director |
| Shih Chang Wu | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
18805 Cox Avenue Suite 250
Saratoga, CA, 95070
Saratoga, CA, 95070